Development of a multivariate prediction model to identify individual case safety reports which require clinical review-Reference-Cited by-同舟云学术

Development of a multivariate prediction model to identify individual case safety reports which require clinical review

Published:2022-10-21 Issue:12 Volume:31 Page:1300-1307
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiology and Drug

Author:

Gosselt Helen R.¹^ORCID,Bazelmans Elizabeth A.¹,Lieber Thomas¹,van Hunsel Florence P. A. M.¹^ORCID,Härmark Linda¹

Affiliation:

1. Netherlands Pharmacovigilance Centre Lareb 's‐Hertogenbosch The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5553

Reference38 articles.

1. Ministry of Health CIMed.Safety of medicines. A guide to detecting and reporting adverse drug reations. 2003. Accessed March 28 2022 https://www.who.int/medicines/areas/quality_safety/safety_efficacy/Mozambiqueguidelines.pdf.

2. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

3. Incidence of Adverse Drug Reactions in Hospitalized Patients

4. Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies

5. Clinical and economic burden of adverse drug reactions

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Pilot, Predictive Surveillance Model in Pharmacovigilance Using Machine Learning Approaches;Advances in Therapy;2024-05-05

2. Navigating duplication in pharmacovigilance databases: a scoping review;BMJ Open;2024-04

3. Will the future of pharmacovigilance be more automated?;Expert Opinion on Drug Safety;2023-07-03

4. Natural language processing for automated triage and prioritization of individual case safety reports for case-by-case assessment;Frontiers in Drug Safety and Regulation;2023-02-07